Slovakia ordered 340,000 doses of Nuvaxovid vaccine from Novavax – TVNOVINY.sk

The Slovak Republic contracted 340,000 doses of Nuvaxovid from Novavax, which the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use recommended on Monday for conditional registration. They should arrive in Slovakia during the first half of 2022. He stated the communication department of the Ministry of Health of the Slovak Republic.

“Several experts recommend using this vaccine as the third dose of the vaccine, a protein vaccine is also recommended for autoimmune diseases,” the health department said.

The EMA recommended the conditional registration of the fifth COVID-19 vaccine.

Nuvaxovid is a protein-based vaccine for adults aged 18 and over. According to the EMA assessment, it meets all requirements for safety, efficiency and quality. The EMA will continue to monitor the efficacy and safety of the vaccine through reporting systems in individual Member States as well as through further studies.

The European Commission will soon decide on the registration of the vaccine. The decision will automatically apply in all EU Member States.